Literature DB >> 20529483

Complete resolution of oral Kaposi's sarcoma achieved by changing immunosuppression: a case report.

Y Johari1, M L Nicholson.   

Abstract

A 38-year-old Afro-Caribbean woman, who was pre-dialysis with polycystic kidney disease, received a live-donor kidney transplant from her 55-year-old mother. This study documents her imunosuppression therapy including resolution of an oral Kaposi's sarcoma and explores the many underlying problems with converting to an mTOR inhibitor.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20529483      PMCID： PMC5696958          DOI： 10.1308/147870810X12699662980475

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN： 0035-8843            Impact factor:   1.891


  3 in total

1.  For organ transplant recipients, cancer threatens long-term survival.

Authors:  Karen Ross
Journal:  J Natl Cancer Inst       Date:  2007-03-21       Impact factor: 13.506

2.  Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies.

Authors:  H Myron Kauffman; Wida S Cherikh; Yulin Cheng; Douglas W Hanto; Barry D Kahan
Journal:  Transplantation       Date:  2005-10-15       Impact factor: 4.939

3.  Changes in the immune responses against human herpesvirus-8 in the disease course of posttransplant Kaposi sarcoma.

Authors:  Patrizia Barozzi; Chiara Bonini; Leonardo Potenza; Michele Masetti; Gianni Cappelli; Paola Gruarin; Denise Whitby; Giorgio E Gerunda; Anna Mondino; Giovanni Riva; Daniela Vallerini; Chiara Quadrelli; Raffaella Bosco; Fabio Ciceri; Claudio Bordignon; Thomas F Schulz; Giuseppe Torelli; Mario Luppi
Journal:  Transplantation       Date:  2008-09-15       Impact factor: 4.939
  3 in total
  1 in total

1.  Mucosal Kaposi sarcoma, a Rare Cancer Network study.

Authors:  Juliette Thariat; Youlia Kirova; Terence Sio; Olivier Choussy; Hans Vees; Ulrich Schick; Gilles Poissonnet; Esma Saada; Antoine Thyss; Robert C Miller
Journal:  Rare Tumors       Date:  2012-10-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.